Current Research Studies

C4591048_OMI

COVID-19 Vaccine Research Study

Condition: Infectious Disease
Phase: II/III
Clinicaltrials.gov ID: NCT05543616

What is the goal of the study?

A multi-pronged, multi-phased study looking at simplifying the mRNA based COVID-19 vaccine schedule in children.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Janet Englund
Study Team Member: Rachel Buchmeier, Rachel.Buchmeier@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.